Valti

Aastrom Biosciences develops products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell adult stem cell technology. Aastrom's TRC products contain large numbers of stromal, stem and progenitor cells that are produced from a small amount of bone marrow cells originating from patients. Its patented AastromReplicell system, an industry-unique automated cell product manufacturing platform, was developed for the production of standardized, patient-specific TRC products. TRC products have been used safely in humans as a substitute for bone marrow stem cells and are currently in clinical trials for bone grafting and blood vessel regeneration applications. Aastrom Biosciences is located in Ann Arbor, Mich., and trades on the NASDAQ under the symbol ASTM.

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website

Acambis is a biotechnology company based in Cambridge, MA. The company focuses on research and development in the field of vaccines. Acambis is dedicated to advancing vaccine technologies to address global health challenges, with a strong emphasis on innovation and collaboration in the scientific community. Generated from their business information